Germline ATBFI mutations and prostate cancer risk

Prostate

Volumn 66, Issue 10, 2006, Pages 1082-1085

  Xu, Junyan ^a,b   Sauvageot, Jurga ^b   Ewing, Charles M ^b   Sun, Jielin ^b   Liu, Wennuan ^a   Isaacs, Sarah D ^b   Wiley, Kathleen E ^b   Diaz, Lina ^a   Zheng, S Lilly ^a   Walsh, Patrick C ^b   Isaacs, William B ^b,c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c Marburg 115 ^*  (United States)

Author keywords

Association; ATBF1; Hereditary; Mutation; Prostate cancer

Indexed keywords

DNA; PYRIMIDINE; ATBF1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN;

ADULT; ARTICLE; ATBF1 GENE; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; FAMILIAL CANCER; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; ALLELE; BLOOD; CHEMISTRY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE; PROSTATE TUMOR; RISK FACTOR;

ALLELES; CODON; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE DELETION; GENE FREQUENCY; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM-LINE MUTATION; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 33745300164     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20430     Document Type: Article

References (10)

1. Kaspar P, Dvorakova M, Kralova J, Pajer P, Kozmik Z, Dvorak M. Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein. J Biol Chein 1999;274:14422-14428.
2. Ninomiya T, Mihara K, Fushimi K, Hayashi Y, Hashimoto-Tamaoki T, Tamaoki T. Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma. Hepatology 2002;35:82-87.
3. Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris CC, Riabowol K. ING1 represses transcription by direct DNA binding and through effects on p53. Cancer Res 2003;63:5785-5792.
4. Sun X, Frierson HF, Clien C, Li C, Ran Q, Otto KB, Cantarel BL, Vessella RL, Gao AC, Petros J, Miura Y, Simons JW, Dong JT. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet 2005;37:407-412.
5. Dong JT. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 2001;20:173-193.
6. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 1993;53:3869-3873.
7. Xu J, Zheng SL, Carpten JD, Nupponen NN, Robbins CM, Mestre J, Moses TY, Faith DA, Kelly BD, Isaacs SD, Wiley KE, Ewing CM, Bujnovszky P, Chang B, Bailey-Wilson J, Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet 2002;68:901-911.
8. Weir BS. Genetic data analysis II: Methods for discrete population genetic data. Sunderland, MA: Sinauer Association, Inc. Publishers; 1996.
9. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL, Nordeen SK, Miller GJ, Lucia MS. Molecular characterization of human prostate carcinoma cell lines. Prostate 2003;57(3):205-225.
10. Suzuki H, Komiya A, Aida S, Akimoto S, Shiraishi T, Yatani R, Igarashi T, Shimazaki J. Microsatelite instability and other molecular abnormalities in human prostate cancer. Jpn. J Cancer Res 1995;86:956-961